IDH2 and central nervous system cancer: Glioblastomas, although previously categorized under grade 4 gliomas, are now considered biologically and molecularly distinct entities, namely, glioblastoma IDH-wildtype and IDH-mutant grade 4 astrocytoma, based on ‘the present’ World Health Organization classification of brain tumors.